Getting the lowdown on GLO2
Researchers publish new data on the enzyme glyoxalase II and its role in cellular metabolism
Metabolism
Developing a cell therapy control switch
Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies
miRagen brings in Viridian Therapeutics
The acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease
Duke University and eGenesis team up on xenotransplantation
Pair announces research collaboration leveraging eGenesis’ genome engineering and transgenic production capabilities to conduct in-vivo testing of pancreatic islet cell xenotransplants
An API boost
Evonik announces first stage of program to increase contract manufacturing in Germany
SEEK and ye shall find
Thrive’s blood test reportedly identifies multiple types of cancer
Preventing height impairment and its complications
QED Therapeutics doses first child in Phase 2 clinical trial of the investigational medicine infigratinib in achondroplasia
Intabio introduces Blaze for biotherapeutics
Intabio launches their Blaze System in the hopes of accelerating biotherapeutic development
Novel pathway for NASH
CN Bio and Cambridge University identify a regulatory pathway that may be driving the problematic liver disease
Making a deal on ADCs
Trio Pharmaceuticals and Ajinomoto enter into development collaboration
